Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Allogeneic Hematopoietic Cell Transplantation From HLA-matched Donor After Flu-Mel-PTCy Versus Flu-Mel-ATG Reduced-intensity ConditioningBlood Protein Disorders, Hemic and Lymphatic Diseases, Hodgkins lymphoma, Leukemia, B-Cell, Myeloproliferative Disorders, Neoplasms by Histologic Type, Neoplasms by Site, bone marrow disorder, cardiovascular disorder, graft versus host disease, hematologic disorder, hematopoietic and lymphoid system neoplasm, hemorrhagic disease, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoma, lymphoproliferative syndrome, monoclonal gammopathy, myelodysplastic syndrome, neoplasm, non-Hodgkin lymphoma, plasma cell neoplasm, vascular disorder, vascular hemostatic diseaseRecruitingPhase 22022-10-12NCT03852407

2 results · Page 1 of 1

Swipe the table sideways for more columns.

10 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
AZ Delta RoeselareRoeselareBelgium2
Az Sint Jan BruggeBrugesBelgium5
CHU de LiègeLiègeBelgium29
CHU UCL Namur GodinneYvoirBelgium1
IJ BordetBrusselsBelgium1
UCL St LucBrusselsBelgium1
UZ BrusselBrusselsBelgium45
UZ GentGhentBelgium113
UZ LeuvenLeuvenBelgium236
ZNA StuivenbergAntwerpBelgium5